Page 1 | Search Results | Blood | American Society of Hematology

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Platelet factor 4/heparin complexes present epitopes differently on solid-phase vs platelet surfaces

Thi-Huong Nguyen, Andreas Greinacher

Blood (2017) 129 (26): 3498–3501.

https://doi.org/10.1182/blood-2017-02-769786

Published: 2017

Includes: Supplemental data

Journal Articles

ABL001, a Potent, Allosteric Inhibitor of BCR-ABL, Exhibits Safety and Promising Single- Agent Activity in a Phase I Study of Patients with CML with Failure of Prior TKI Therapy

Oliver G. Ottmann, MD, Giuliana Alimena, Daniel J. DeAngelo, MD PhD, Yeow-Tee Goh, MBBS, MMed, Michael C. Heinrich, MD, Andreas Hochhaus, MD, Timothy P. Hughes, MD MBBS, FRACP, FRCPA, Francois-Xavier Mahon, MD PhD Professor, Michael J. Mauro, MD, Hironobu Minami, MD D.MDSci., Marie Huong Nguyen, MD, Delphine Rea, Juan Luis Steegmann, MD, Arkendu Chatterjee, Varsha Iyer, Noelia Martinez, Gary J. Vanasse, MD, Kim Dong-Wook, MD PhD

Blood (2015) 126 (23): 138.

https://doi.org/10.1182/blood.V126.23.138.138

Published: 2015

Journal Articles

Prolonged aPTT Relative to Anti-Xa Is Associated with Increased 30-Day Mortality in Hospitalized Patients Treated with Unfractionated Heparin

Jing Jin, MD, Elizabeth Price, MD, MPH, Huong Nguyen, MD, Gomathi Krishnan, PhD, Raymond Balise, PhD, Raffick AR Bowen, MLT(CSMLS), PhD, DClChem, FCACB,, James L. Zehnder, MD

Blood (2011) 118 (21): 1248.

https://doi.org/10.1182/blood.V118.21.1248.1248

Published: 2011

Journal Articles

Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration

Thomas H. Sisson, Mai-Huong Nguyen, Bi Yu, Margaret L. Novak, Richard H. Simon, Timothy J. Koh

Blood (2009) 114 (24): 5052–5061.

https://doi.org/10.1182/blood-2008-12-196212

Published: 2009

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Platelet factor 4/heparin complexes present epitopes differently on solid-phase vs platelet surfaces

ABL001, a Potent, Allosteric Inhibitor of BCR-ABL, Exhibits Safety and Promising Single- Agent Activity in a Phase I Study of Patients with CML with Failure of Prior TKI Therapy

Prolonged aPTT Relative to Anti-Xa Is Associated with Increased 30-Day Mortality in Hospitalized Patients Treated with Unfractionated Heparin

Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration

Email alerts

ASH Publications

American Society of Hematology

Update search

Platelet factor 4/heparin complexes present epitopes differently on solid-phase vs platelet surfaces

ABL001, a Potent, Allosteric Inhibitor of BCR-ABL, Exhibits Safety and Promising Single- Agent Activity in a Phase I Study of Patients with CML with Failure of Prior TKI Therapy

Prolonged aPTT Relative to Anti-Xa Is Associated with Increased 30-Day Mortality in Hospitalized Patients Treated with Unfractionated Heparin

Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only